CLINICAL NEXT GENERATION SEQUENCING REVEALS AN
H3F3A GENE AS A NEW POTENTIAL GENE CANDIDATE
FOR MICROCEPHALY ASSOCIATED WITH SEVERE
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY
AND GROWTH RETARDATION
Maver A1, Čuturilo G2,3, Ruml Stojanović J3, Peterlin B1,*
*Corresponding Author: Professor Borut Peterlin, Clinical Institute of Genomic Medicine, University
Medical Center Ljubljana, Šlajmerjeva 4, 1000 Ljubljana, Slovenia. Tel: +38615401137. E-mail:
borut.peterlin@kclj.si
page: 65
|
|
REFERENCES
1. Kalmin MM, Gower EW, Stringer EM, Bowman
NM, McQuade ET, Westreich D. Misclassification
in defining and diagnosing microcephaly. Paediatr
Perinat Ep. 2019; 33(4): 286-390.
2. Woods GC, Parker A. Investigating microcephaly.
Arch Dis Child. 2013; 98(9):707-713.
3. Boonsawat P, Joset P, Steindl K, Oneda B, Gogoll L,
Azzarello-Burri S, et al. Elucidation of the phenotypic
spectrum and genetic landscape in primary and
secondary microcephaly. Genet Med. 2019; 21(9):
2043-2058.
4. Hagen M, Pivarcsi M, Liebe J, Bernuth H, Didonato
N, Hennermann JB, et al. Diagnostic approach
to micro cephaly in childhood: A two center study
and review of the literature. Dev Med. Child Neurol.
2014; 56(8): 732-41.
5. Maver A, Čuturilo G, Kovanda A, Miletić A, Peterlin
B. Rare missense TUBGCP5 gene variant in a patient
with primary microcephaly. Eur J Med Genet. 2019;
65(12): 103598.
6. Tumienė B, Maver A, Writzl K, Hodžić A, Čuturilo
G, Kuzmanić Šamija R, et al. Diagnostic exome sequencing
of syndromic epilepsy patients in clinical
practice. Clin Genet. 2018; 93(5):1057-1062.
7. DePristo MA, Banks E, Poplin R, Garimella KV,
Maguire JR, Hartl C, et al. A framework for variation
discovery and genotyping using next-generation DNA
sequencing data. Nat Genet. 2011; 43(5): 491-498.
8. Lucas AF, Wang G, Scheet P, Peng B. Integrated annotation
and analysis of genetic variants from nextgeneration
sequencing studies with variant tools.
Bioinformatics. 2012; 28(3): 421-422.
9. Wang K, Li M, Hakonarson H. ANNOVAR: Functional
annotation of genetic variants from highthroughput
sequencing data. Nucleic Acids Res.
2010; 38(16): e164-e164.
10. Cingolani P, Platts A, Wang L, Coon M, Nguyen T,
Wang L, et al. A program for annotating and predicting
the effects of single nucleotide polymorphisms,
SnpEff. Fly (Austin). 2012; 6(2): 80-92.
11. Liu X, Jian X, Boerwinkle E. dbNSFP v2.0: A database
of human non synonymous SNVs and their
functional predictions and annotations. Hum Mutat.
2013; 34(9): E2393-E402.
12. Davydov EV, Goode DL, Sirota M, Cooper GM,
Sidow A, Batzoglou S. Identifying a high fraction of
the human genome to be under selective constraint
using GERP++. PLoS Comput Biol. 2010; 6(12):
e1001025.
13. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein
WS, Church DM, et al. ClinVar: Public archive of
relationships among sequence variation and human
phenotype. Nucleic Acids Res. 2014; 42(Database
issue): D980-D985.
14. Maze I, Wenderski W, Noh K-M, Bagot RC, Tzavaras
N, Purushothaman I, et al. Critical role of histone
turnover in neuronal transcription and plasticity. Neuron.
2015; 87(1): 77-94.
15. Couldrey C, Carlton M, Nolan P, Colledge W, Evans
M. A retroviral gene trap insertion into the Histone
3.3A gene causes partial neonatal lethality, stunted
growth, neuromuscular deficits and male sub-fertility
in transgenic mice. Hum Mol Genet. 1999; 8(13):
2489-2495.
16. Schwartzentruber J, Korshunov A, Liu X-Y, Jones
DT, Pfaff E, Jacob K, et al. Driver mutations in
histone H3.3 and chromatin remodelling genes in
paediatric glio-blastoma. Nature. 2012; 482(7384):
226-231.
17. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay
N, Loo P, et al. Distinct H3F3A and H3F3B driver
mutations define chondroblastoma and giant cell tumor
of bone. Nat Genet. 2013; 45(12): 1479-1482.
18. Nair DR, Bhoj E. 3548 De novo germline variants in
Histone 3 Family 3A (H3F3A) and Histone 3 Family
3B (H3F3B) cause a severe neurodegenerative
disorder and functional effects unique from their somatic
mutations. (Abstract). J Clin Transl Sci. 2019;
3(Suppl 1): 103. doi: 10.1017/cts.2019.235. (https://
www.ncbi.nlm.nih.gov/pmc/ articles/PMC6799666/).
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
